Source: International Congress 2019 – New towards old therapies in airway diseases
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
T. Harrison (Nottingham, United Kingdom), G. Canonica (Milan, Italy), K. Gemzoe (Uxbridge, United Kingdom), A. Maxwell (Stevenage, United Kingdom), S. Yang (Collegeville, United States of America), S. Joksaite (Uxbridge , United Kingdom), R. O’Reilly (Stevenage, United Kingdom), M. Van Dyke (Upper Providence, United States of America), F. Albers (Research Triangle Park, United States of America), N. Kwon (Brentford, United States of America). Late Breaking Abstract - Effectiveness and safety of mepolizumab in real-world clinical practice: the REALITI-A study. 2104

Member's Comments

No comment yet.

Related content which might interest you: Late Breaking Abstract - Long-term safety of pirfenidone in a real-world setting: final results from the prospective, observational PASSPORT registry Source: International Congress 2017 – Late-breaking findings in pulmonary diseases Year: 2017 Late Breaking Abstract - Efficacy and safety of tezepelumab in adults with severe asthma: A randomized phase 2 study Source: International Congress 2017 – Late-breaking studies in asthma and COPD Year: 2017 Late Breaking Abstract - International, prospective real-world study of mepolizumab in patients with severe asthma at one year: REALITI-A Source: Virtual Congress 2021 – Advances in asthma treatment Year: 2021 Late Breaking Abstract - Durable clinical benefit of benralizumab following oral corticosteroid reduction: The PONENTE study Source: Virtual Congress 2021 – Severe asthma: evaluation using patient-reported outcome measures (PROMs) and biomarkers, comorbidities and treatments Year: 2021 Late Breaking Abstract - RECEIVER trial: sustained use and improved outcomes with digitally supported COPD co-management Source: Virtual Congress 2021 – E-health for COVID-19 Year: 2021 Late Breaking Abstract - Efficacy and safety of macitentan in portopulmonary hypertension: the PORTICO trial Source: International Congress 2018 – Risk stratification in treatment of pulmonary arterial hypertension Year: 2018 Late Breaking Abstract - Telerehabilitation compared to centre-based pulmonary rehabilitation: a randomised controlled equivalence trial. Source: Virtual Congress 2020 – ALERT: Ventilation and rehabilitation Year: 2020 Late Breaking Abstract - Objective physical activity as a clinical trial outcome in patients with COPD: a view on the literature from a task force of experts in the field Source: International Congress 2019 – Breathing, posture and physical activity in respiratory disease patients Year: 2019 Efficacy and safety of omalizumab in real-life practice in India Source: Annual Congress 2012 - Asthma: risk factors and effect of anti-IgE Year: 2012 Late Breaking Abstract - Evaluating the feasibility, safety, and efficacy of senolytics in idiopathic pulmonary fibrosis Source: International Congress 2019 – Idiopathic pulmonary fibrosis and surroundings Year: 2019 Late Breaking Abstract - Post-trial follow-up after a randomized clinical trial of COVID-19 convalescent plasma. Source: Virtual Congress 2021 – Emerging evidence on sub-acute and long COVID-19 Year: 2021 Late Breaking Abstract - Improving adherence to prescribing remdesivir in COVID-19 Source: Virtual Congress 2021 – Respiratory infections Year: 2021 Late Breaking Abstract - Pharmacological and clinical management of severe asthma in 9 countries: An international survey of clinicians. Source: Virtual Congress 2020 – Advances in asthma treatment Year: 2020 Efficacy and safety of new drugs for M/XDR-TB: what have we learned from observational studies? Source: International Congress 2019 – Recent developments and future perspectives in the diagnosis and treatment of tuberculosis Year: 2019 Late Breaking Abstract - Tocilizumab administration for the treatment of hospitalised patients with COVID-19: A systematic review and meta-analysis Source: Virtual Congress 2021 – Challenges of COVID-19 management at short and long-term Year: 2021 Late Breaking Abstract - Automated coaching for physical activity in COPD patients: results from a pilot study Source: International Congress 2017 – Innovation in pulmonary rehabilitation and chronic care Year: 2017 Late Breaking Abstract - The humanistic burden of asthma patients uncontrolled on ICS-LABA: a systematic literature review Source: Virtual Congress 2020 – Inhaled corticosteroids and bronchodilator studies in asthma Year: 2020 Late Breaking Abstract - Efficacy and safety of azithromycin maintenance therapy in primary ciliary dyskinesia – The BESTCILIA randomized placebo-controlled trial Source: International Congress 2019 – ALERT: Abstracts Leading to Evolution in Respiratory Medicine Trials: Intensive care and infection Year: 2019 Adaptive servoventilation in clinical practice: beyond SERVE-HF? Source: ERJ Open Res, 3 (4) 00078-2017; 10.1183/23120541.00078-2017 Year: 2017 Late Breaking Abstract - Influence of salbutamol use on symptomatic outcomes with maintenance bronchodilators: a pre-specified analysis of the EMAX trial Source: International Congress 2019 – New towards old therapies in airway diseases Year: 2019